Compare ATEX & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATEX | OMCL |
|---|---|---|
| Founded | 1997 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Computer Manufacturing |
| Sector | Telecommunications | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 2014 | 2000 |
| Metric | ATEX | OMCL |
|---|---|---|
| Price | $104.70 | $46.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $50.00 | ★ $55.83 |
| AVG Volume (30 Days) | 504.6K | ★ 689.6K |
| Earning Date | 02-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 891.80 | N/A |
| EPS | ★ 4.83 | 0.25 |
| Revenue | $6,501,000.00 | ★ $787,309,000.00 |
| Revenue This Year | $2.70 | $6.77 |
| Revenue Next Year | $10.04 | $5.22 |
| P/E Ratio | ★ $21.78 | $184.14 |
| Revenue Growth | 7.79 | ★ 9.93 |
| 52 Week Low | $17.58 | $26.85 |
| 52 Week High | $111.90 | $51.84 |
| Indicator | ATEX | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 67.57 | 67.49 |
| Support Level | $20.99 | $43.34 |
| Resistance Level | $111.90 | $51.62 |
| Average True Range (ATR) | 7.51 | 2.08 |
| MACD | -0.33 | 0.60 |
| Stochastic Oscillator | 79.79 | 95.12 |
Anterix Inc is the holder of licensed 900 MHz spectrum (896-901/935-940 MHz) with coverage spanning the contiguous United States, Hawaii, Alaska, and Puerto Rico. The Company is focused on commercializing its spectrum assets and delivering intelligent infrastructure solutions, including private broadband networks, tower access, and turnkey connectivity management, to utility and critical infrastructure enterprises. It provides mission-critical private 900 MHz spectrum to the utility sector and integrated deployment solutions that support a secure, resilient, and decarbonized future. Its solutions include 900 MHz Private Wireless, TowerX, and CatalyX.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.